Worth reading
33Immaterial
Scored from 4 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
3835200
Shares (number of underlying shares)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Stock acquisition rights through solicitation (paid stock options)
Who receives how much
3,835,200 common shares (38,352 stock acquisition rights)
7 directors and audit & supervisory board members of the Company (700 rights), 253 employees of the Company (23,343 rights), 9 directors and audit & supervisory board members of the Company's subsidiaries (850 rights), and 149 employees of the Company's subsidiaries (13,459 rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
¥319.4 per share. Adjustment provision and adjustment floor: Not disclosed
Exercise period
1 June 2026–31 October 2027
Number of Stock Acquisition Rights
Total issued: 38,352 rights; unexercised balance: 0 rights
Reason for acquisition without consideration
All rights lapsed after it was determined that the exercise conditions would not be met
Categories and Number of Persons Covered
7 directors and audit & supervisory board members of the Company (700 rights), 253 employees of the Company (23,343 rights), 9 directors and audit & supervisory board members of the Company's subsidiaries (850 rights), and 149 employees of the Company's subsidiaries (13,459 rights)
Most recent equity financing
8 September 2023: Notice Concerning the Issuance of Stock Acquisition Rights Offered for Subscription (Paid Stock Options), 31 October 2023: Notice Concerning the Finalization of the Issuance Terms of Stock Acquisition Rights Offered for Subscription (Paid Stock Options)
Impact on Business Performance
This matter will have no impact on consolidated results for the fiscal year ending March 2027.
| Item | Details |
|---|---|
| Type of issuance or disposal | Stock acquisition rights through solicitation (paid stock options) |
| Number of shares to be issued or disposed of | 3,835,200 common shares (38,352 stock acquisition rights) |
| Intended allottee | 7 directors and audit & supervisory board members of the Company (700 rights), 253 employees of the Company (23,343 rights), 9 directors and audit & supervisory board members of the Company's subsidiaries (850 rights), and 149 employees of the Company's subsidiaries (13,459 rights) |
| Exercise price | ¥319.4 per share. Adjustment provision and adjustment floor: Not disclosed |
| Exercise period | 1 June 2026–31 October 2027 |
| Number of Stock Acquisition Rights | Total issued: 38,352 rights; unexercised balance: 0 rights |
| Reason for acquisition without consideration | All rights lapsed after it was determined that the exercise conditions would not be met |
| Categories and Number of Persons Covered | 7 directors and audit & supervisory board members of the Company (700 rights), 253 employees of the Company (23,343 rights), 9 directors and audit & supervisory board members of the Company's subsidiaries (850 rights), and 149 employees of the Company's subsidiaries (13,459 rights) |
| Most recent equity financing | 8 September 2023: Notice Concerning the Issuance of Stock Acquisition Rights Offered for Subscription (Paid Stock Options), 31 October 2023: Notice Concerning the Finalization of the Issuance Terms of Stock Acquisition Rights Offered for Subscription (Paid Stock Options) |
| Impact on Business Performance | This matter will have no impact on consolidated results for the fiscal year ending March 2027. |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Based on the figures in the consolidated balance sheet and consolidated income statement included in the securities report for the fiscal year ending March 2026, it was determined that the exercise conditions stipulated in the terms of issue of the stock acquisition rights would not be met. The exercise conditions require all of the following to be achieved for the fiscal year ending March 2026: ordinary revenue of ¥250 billion, ordinary profit of ¥45 billion, and ROE of 8%.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.